Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
about
The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis.Post-brushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: The Papanicolaou Society of Cytopathology GuidelinesItalian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLCRadiochemotherapy-induced changes of tumour vascularity and blood supply estimated by dynamic contrast-enhanced CT and fractal analysis in malignant head and neck tumours.Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumorsMultivisceral resection of pancreatic neuroendocrine tumours: a report of two casesTreatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.Construction of tissue microarrays from core needle biopsies - a systematic literature review.High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancerAssessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Histopathology of gastrointestinal neuroendocrine neoplasms.Uptake Difference by Somatostatin Receptors in a Patient with Neuroendocrine Tumor: 99mTc-Octreotide Uptake in the Lung without Uptake in Liver LesionsExtensive multiarterial resection attending total duodenopancreatectomy and adrenalectomy for MEN-1-associated neuroendocrine carcinomas.CT texture analysis in colorectal liver metastases: A better way than size and volume measurements to assess response to chemotherapy?A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasmsDiscordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas.Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification.Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.A woman with metastatic pancreatic neuroendocrine tumor.Ki-67 as a prognostic marker according to breast cancer molecular subtype.Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity.Surgical treatment and survival in patients with liver metastases from neuroendocrine tumors: a meta-analysis of observational studies.Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.Single institutional series of neuroendocrine tumors managed in the Australian Capital Territory.Neuroendocrine tumors of the pancreas: current concepts and controversies.Postbrushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: the Papanicolaou Society of Cytopathology guidelines.The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.Pathology diagnosis of pancreatic neuroendocrine tumors.Childhood extracranial neoplasms: the role of imaging in drug development and clinical trials.Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art.Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis.Clinical utility of endoscopic ultrasound-guided fine-needle aspiration in mixed adenoneuroendocrine carcinoma with signet-ring cells of the pancreas: a case report and review of the literature.Cytology assessment can predict survival for patients with metastatic pancreatic neuroendocrine neoplasms.The impact of immunohistochemistry on the classification of lung tumors.Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors.The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms.
P2860
Q30252003-0F60AB4E-4830-47C4-AB39-CA1142D7892CQ34127306-B7A95F19-F202-47F8-A14B-281437291340Q34157385-B3701DA9-3524-4077-B486-3921F81AC350Q34695293-F4B7BE09-62EB-4928-AE53-F0A3DC8CC8F9Q34776519-DF19C1EC-8DB9-4EBB-94BB-BC5906A38522Q35163126-2964FF99-6097-4681-8E18-2497931305B5Q35219502-C27AEA2B-FECA-4C06-BC15-451C2766FB3AQ35371197-6D980488-9668-47F7-BEDC-5E0F6EEEB240Q35440550-CC68E366-F459-4428-A301-7A3C029D01F4Q35743491-49C1B065-F336-498D-AC51-50607BA08AA9Q36014349-8CB166C3-45B4-450B-91A2-67B2002AACDFQ36421023-7F033E47-C89B-44F3-A05B-6C89ECF1CEB3Q36551032-5034FF89-3403-455D-A87C-E7DB199E0998Q36556526-DC8F7775-25C1-4082-9C16-B1AB3AF7CDBBQ36638258-65454762-6ED9-4612-9BAE-2D3B99FDDD2CQ36719842-90FDB738-63B5-47FD-A0F7-DB188460E546Q36857533-33178061-F015-4EAB-A364-0362A4627D8EQ36879154-D4619734-9832-4E3C-8F96-5F2F36305024Q37182620-6AB6B48B-9FA0-4853-ABB0-6DF57452E95FQ37373285-3685CD2F-58C0-4FF7-82E5-F58010998135Q37478823-A4B76FA7-68C7-4909-9ED7-9A8D9EABB910Q37584857-7861326C-EB72-4B6D-8D21-83956F623567Q37596690-EC92D092-4C14-4594-840F-FC5F7A993BD8Q37701724-CC96FF0F-943D-4513-8D91-957E54A6B2BAQ38091072-CE065DB7-6998-4EEE-806D-0CBB02D235D2Q38113157-8F3FDFA8-50BF-4D4B-972A-320BDFB44210Q38155942-42FBAC5B-3FB7-440C-B13E-17B83317CF79Q38178882-2ED98E27-AF10-4CE0-B0CC-6A14BBB73EADQ38196789-538AAB87-F659-4DD9-BA66-E218D1C44DF2Q38202029-A4C6F719-8DB5-40AF-B2D9-8D357BD6B613Q38340420-B7648CF0-B0EB-42BD-BBEF-DAA70C6DBC48Q38516659-4BA59DA6-0C06-4B4A-BB29-039BAF4521C1Q38557054-2781F3CE-8686-4E95-9A8F-E03837280891Q38600057-01B7440C-4BC3-4C22-B415-F9F0B589DF6CQ38701609-D61D8125-7764-48A5-B539-3FCE5FE4098AQ38723945-0FA08246-5CAF-4AF3-B125-ACA77F61DFA3Q38769603-6E00E0E8-9F82-4ED2-9826-EF9125CAB00AQ38822314-92ED96D1-0C1D-4CCB-8C1F-50812BC1EB06Q38856277-D4A63007-BD3E-4136-98BB-27B1207A6EF9Q39459743-91744B87-E440-4A75-BB1E-12E19A6EF5BC
P2860
Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Effect of tumor heterogeneity ...... for prognostic stratification.
@en
Effect of tumor heterogeneity ...... for prognostic stratification.
@nl
type
label
Effect of tumor heterogeneity ...... for prognostic stratification.
@en
Effect of tumor heterogeneity ...... for prognostic stratification.
@nl
prefLabel
Effect of tumor heterogeneity ...... for prognostic stratification.
@en
Effect of tumor heterogeneity ...... for prognostic stratification.
@nl
P2093
P1476
Effect of tumor heterogeneity ...... for prognostic stratification.
@en
P2093
David S Klimstra
Laura H Tang
Zhaohai Yang
P304
P356
10.1097/PAS.0B013E31821A0696
P407
P577
2011-06-01T00:00:00Z